Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
US drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as US$14 billion, people familiar with the matter said on Wednesday.
A Pfizer exit from the consumer health business, which includes lip...